Patients implanted with a wavefront-shaping presbyopia-correcting IOL reported high levels of satisfaction, according to a study presented at the European Society of Cataract and Refractive Surgeons meeting.
Miguel Teus, MD, PhD, presented interim data from a study evaluating the real-world visual outcomes among patients who received the AcrySof IQ Vivity and AcrySof IQ Vivity toric extended vision IOLs (Alcon). The analysis included data from 69 patients who were enrolled at Spanish clinics.
Researchers assessed binocular uncorrected visual acuity at distance, intermediate and near,